Expertise in
1
conditions

Joelle Helou

London, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
London, ON, CA 
OverviewLocationsClinical Research

Overview

Joelle Helou practices in London, Canada. Ms. Helou is highly rated in 1 condition, according to our data. Her top areas of expertise are Prostate Cancer, Breast Cancer, Lung Metastases, Prostatectomy, and Penectomy.

Her clinical research consists of co-authoring 71 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

London, ON, Canada
Other Locations
London, Canada
Toronto, ON, Canada
Lakeridge Health
Oshawa, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase II Study: Stereotactic Ablative Radiotherapy for Renal Tumors
Phase II Study: Stereotactic Ablative Radiotherapy for Renal Tumors
Enrollment Status: Recruiting
Publish Date: February 20, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
Evaluation of the Ductal Carcinoma In Situ Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS
Evaluation of the Ductal Carcinoma In Situ Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS
Enrollment Status: Completed
Publish Date: February 19, 2020
View 1 Less Clinical Trial

71 Total Publications

A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087).
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Helou's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile